| PERIOD ENDING | 31-May-09 | 28-Feb-09 | 30-Nov-08 | 31-Aug-08 | | Total Revenue | 2,615,101 | 2,887,400 | 3,382,509 | 3,264,874 | | Cost of Revenue | 2,466,512 | 2,731,854 | 3,158,796 | 3,034,874 | | | Gross Profit | 148,589 | 155,546 | 223,713 | 230,000 | | | Operating Expenses | | Research Development | 7,198 | 5,754 | 5,655 | 8,603 | | Selling General and Administrative | 125,419 | 111,053 | 131,662 | 123,707 | | Non Recurring | 16,167 | 736,645 | 318,321 | 262 | | Others | 7,612 | 7,673 | 8,035 | 9,653 | | | | Total Operating Expenses | 156,396 | 861,125 | 463,673 | 142,225 | | | | Operating Income or Loss | (7,807) | (705,579) | (239,960) | 87,775 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 139 | 1,063 | (57) | 672 | | Earnings Before Interest And Taxes | (7,668) | (704,516) | (240,017) | 88,447 | | Interest Expense | 19,043 | 20,077 | 23,734 | 23,807 | | Income Before Tax | (26,711) | (724,593) | (263,751) | 64,640 | | Income Tax Expense | 2,528 | 142,018 | 12,363 | 7,729 | | Minority Interest | 477 | 511 | 257 | 580 | | | | Net Income From Continuing Ops | (28,762) | (866,100) | (275,857) | 57,491 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (28,762) | (866,100) | (275,857) | 57,491 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($28,762) | ($866,100) | ($275,857) | $57,491 |
|
0.45% Nasdaq 
0.20%
Income Statement
